Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study

Authors: Atsuko Sekita, Hisatomi Arima, Toshiharu Ninomiya, Tomoyuki Ohara, Yasufumi Doi, Yoichiro Hirakawa, Masayo Fukuhara, Jun Hata, Koji Yonemoto, Yukiko Ga, Takanari Kitazono, Shigenobu Kanba, Yutaka Kiyohara

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Uncertainty still surrounds the association between metabolic syndrome (MetS) and depression. We aimed to evaluate the association between MetS and elevated depressive symptoms in a general Japanese population.

Methods

This is a cross-sectional survey of 3,113 community-dwelling individuals aged 40 years or over. MetS was defined according to the joint interim statement. MetS was diagnosed when a subject had three or more of the following components: 1) central obesity (waist circumference ≥90 cm for men, ≥80 cm in for women); 2) elevated blood pressure (≥130/85 mmHg or current use of antihypertensive medication); 3) hypertriglyceridemia (≥1.7 mmol/L); 4) low HDL cholesterol (< 1.0 mmol/L for men, < 1.3 mmol/L for women); and 5) elevated fasting plasma glucose (≥5.55 mmol/L or current use of antidiabetic medication). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The age- and multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI) were estimated using a logistic regression model.

Results

Elevated depressive symptoms were observed in 4.3% of male and 6.3% of female participants. In men, the age-adjusted prevalence of elevated depressive symptoms was significantly higher in subjects with MetS than in those without (7.1% versus 3.6%, p = 0.04). The prevalence of elevated depressive symptoms rose progressively as the number of MetS components increased (3.5%, 3.6%, 5.8%, and 9.2% in male subjects with 0–1, 2, 3, and ≥4 components, respectively; p = 0.02 for trend). This association remained significant even after adjustment for age, marital status, history of cardiovascular disease, smoking habit, alcohol intake, and regular exercise. In women, on the other hand, there was no clear association between MetS and depressive symptoms.

Conclusions

MetS was associated with elevated depressive symptoms in a general population of Japanese men.
Literature
1.
go back to reference Murray CJL, Lopez AP: Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1996, Cambridge: Harvard University Press Murray CJL, Lopez AP: Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1996, Cambridge: Harvard University Press
2.
go back to reference Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A: No health without mental health. Lancet. 2007, 370: 859-877. 10.1016/S0140-6736(07)61238-0.CrossRefPubMed Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A: No health without mental health. Lancet. 2007, 370: 859-877. 10.1016/S0140-6736(07)61238-0.CrossRefPubMed
3.
go back to reference Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB: Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012, 35: 1171-1180. 10.2337/dc11-2055.CrossRefPubMedPubMedCentral Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB: Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012, 35: 1171-1180. 10.2337/dc11-2055.CrossRefPubMedPubMedCentral
4.
go back to reference Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawu A, et al: Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia. 1993, 36: 1198-1203. 10.1007/BF00401066.CrossRefPubMed Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawu A, et al: Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia. 1993, 36: 1198-1203. 10.1007/BF00401066.CrossRefPubMed
5.
go back to reference Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y: High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008, 28: 1385-1391. 10.1161/ATVBAHA.107.157164.CrossRefPubMed Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y: High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008, 28: 1385-1391. 10.1161/ATVBAHA.107.157164.CrossRefPubMed
6.
go back to reference Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T, et al: Trends in prevalence of Alzheimer’s disease and vascular dementia in a Japanese community: the Hisayama study. Acta Psychiatr Scand. 2010, 122: 319-325. 10.1111/j.1600-0447.2010.01587.x.CrossRefPubMed Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T, et al: Trends in prevalence of Alzheimer’s disease and vascular dementia in a Japanese community: the Hisayama study. Acta Psychiatr Scand. 2010, 122: 319-325. 10.1111/j.1600-0447.2010.01587.x.CrossRefPubMed
7.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
8.
go back to reference Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Measure. 1977, 1: 385-401. 10.1177/014662167700100306.CrossRef Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Measure. 1977, 1: 385-401. 10.1177/014662167700100306.CrossRef
9.
go back to reference Roberts RE, Vernon SW: The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry. 1983, 140: 41-46.CrossRefPubMed Roberts RE, Vernon SW: The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry. 1983, 140: 41-46.CrossRefPubMed
10.
go back to reference Sima S, Kano T, Kitamura T, Asai M: A new scale of depressive symptoms (in Japanese). Clinical Psychiatry. 1985, 27: 717-723. Sima S, Kano T, Kitamura T, Asai M: A new scale of depressive symptoms (in Japanese). Clinical Psychiatry. 1985, 27: 717-723.
11.
go back to reference Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the third national health and nutrition examination survey. Psychosom Med. 2004, 66: 316-322. 10.1097/01.psy.0000124755.91880.f4.CrossRefPubMed Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the third national health and nutrition examination survey. Psychosom Med. 2004, 66: 316-322. 10.1097/01.psy.0000124755.91880.f4.CrossRefPubMed
12.
go back to reference Gil K, Radzillowicz P, Zdrojewski T, Pakalska-Korcala A, Chwojnicki K, Piwonski J, Ignaszewska-Wyrzykowska A, Zaluga L, Mielczarek M, Landowski J, et al: Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD project. Kardiol Pol. 2006, 64: 464-469.PubMed Gil K, Radzillowicz P, Zdrojewski T, Pakalska-Korcala A, Chwojnicki K, Piwonski J, Ignaszewska-Wyrzykowska A, Zaluga L, Mielczarek M, Landowski J, et al: Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD project. Kardiol Pol. 2006, 64: 464-469.PubMed
13.
go back to reference Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M: Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 birth cohort study. Psychosom Med. 2006, 68: 213-216. 10.1097/01.psy.0000203172.02305.ea.CrossRefPubMed Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M: Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 birth cohort study. Psychosom Med. 2006, 68: 213-216. 10.1097/01.psy.0000203172.02305.ea.CrossRefPubMed
14.
go back to reference Skilton MR, Moulin P, Terra JL, Bonnet F: Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007, 62: 1251-1257. 10.1016/j.biopsych.2007.01.012.CrossRefPubMed Skilton MR, Moulin P, Terra JL, Bonnet F: Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007, 62: 1251-1257. 10.1016/j.biopsych.2007.01.012.CrossRefPubMed
15.
go back to reference Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW: Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinol. 2007, 32: 151-159. 10.1016/j.psyneuen.2006.11.009.CrossRef Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW: Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinol. 2007, 32: 151-159. 10.1016/j.psyneuen.2006.11.009.CrossRef
16.
go back to reference Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE: Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care. 2009, 32: 499-504. 10.2337/dc08-1358.CrossRefPubMedPubMedCentral Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE: Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care. 2009, 32: 499-504. 10.2337/dc08-1358.CrossRefPubMedPubMedCentral
17.
go back to reference Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L: Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry. 2009, 17: 889-898. 10.1097/JGP.0b013e3181b047e3.CrossRefPubMed Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L: Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry. 2009, 17: 889-898. 10.1097/JGP.0b013e3181b047e3.CrossRefPubMed
18.
go back to reference Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E: Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes Metab Res Rev. 2009, 25: 762-767. 10.1002/dmrr.1041.CrossRefPubMed Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E: Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes Metab Res Rev. 2009, 25: 762-767. 10.1002/dmrr.1041.CrossRefPubMed
19.
go back to reference Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H: Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta psychiatr Scand. 2009, 119: 137-142. 10.1111/j.1600-0447.2008.01283.x.CrossRefPubMed Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H: Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta psychiatr Scand. 2009, 119: 137-142. 10.1111/j.1600-0447.2008.01283.x.CrossRefPubMed
20.
go back to reference Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, Comijs HC, Hoogendijk WJ, Deeg DJ, Penninx BW: Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry. 2009, 17: 716-721. 10.1097/JGP.0b013e3181aad5d7.CrossRefPubMed Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, Comijs HC, Hoogendijk WJ, Deeg DJ, Penninx BW: Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry. 2009, 17: 716-721. 10.1097/JGP.0b013e3181aad5d7.CrossRefPubMed
21.
go back to reference East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH: Depressive symptoms and metabolic syndrome in preventive healthcare: the cooper center longitudinal study. Metab Syndr Relat Disord. 2010, 8: 451-457. 10.1089/met.2010.0017.CrossRefPubMed East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH: Depressive symptoms and metabolic syndrome in preventive healthcare: the cooper center longitudinal study. Metab Syndr Relat Disord. 2010, 8: 451-457. 10.1089/met.2010.0017.CrossRefPubMed
22.
go back to reference Kobrosly RW, van Wijngaarden E: Revisiting the association between metabolic syndrome and depressive symptoms. Ann Epidemiol. 2010, 20: 852-855. 10.1016/j.annepidem.2010.08.002.CrossRefPubMed Kobrosly RW, van Wijngaarden E: Revisiting the association between metabolic syndrome and depressive symptoms. Ann Epidemiol. 2010, 20: 852-855. 10.1016/j.annepidem.2010.08.002.CrossRefPubMed
23.
go back to reference Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, Penninx BW: Identifying depressive subtypes in a large cohort study: results from the Netherlands study of depression and anxiety (NESDA). J Clin Psychiatry. 2010, 71: 1582-1589. 10.4088/JCP.09m05398blu.CrossRefPubMed Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, Penninx BW: Identifying depressive subtypes in a large cohort study: results from the Netherlands study of depression and anxiety (NESDA). J Clin Psychiatry. 2010, 71: 1582-1589. 10.4088/JCP.09m05398blu.CrossRefPubMed
24.
go back to reference Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, Kivimaki M, Berr C, Ritchie K: Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care. 2011, 34: 904-909. 10.2337/dc10-1644.CrossRefPubMedPubMedCentral Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, Kivimaki M, Berr C, Ritchie K: Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care. 2011, 34: 904-909. 10.2337/dc10-1644.CrossRefPubMedPubMedCentral
25.
go back to reference Nishina M, Nishina K, Ohira T, Makino K, Iso H: Associations of psychological distress with metabolic syndrome among Japanese urban residents. J Atheroscler Thromb. 2011, 18: 396-402. 10.5551/jat.6692.CrossRefPubMed Nishina M, Nishina K, Ohira T, Makino K, Iso H: Associations of psychological distress with metabolic syndrome among Japanese urban residents. J Atheroscler Thromb. 2011, 18: 396-402. 10.5551/jat.6692.CrossRefPubMed
26.
go back to reference Vogelzangs N, Beekman AT, Boelhouwer IG, Bandinelli S, Milaneschi Y, Ferrucci L, Penninx BW: Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J Clin Psychiatry. 2011, 72: 598-604. 10.4088/JCP.10m06559.CrossRefPubMed Vogelzangs N, Beekman AT, Boelhouwer IG, Bandinelli S, Milaneschi Y, Ferrucci L, Penninx BW: Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J Clin Psychiatry. 2011, 72: 598-604. 10.4088/JCP.10m06559.CrossRefPubMed
27.
go back to reference Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Losch C, Moebus S: Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci. 2012, 262: 313-320. 10.1007/s00406-011-0277-4.CrossRefPubMed Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Losch C, Moebus S: Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci. 2012, 262: 313-320. 10.1007/s00406-011-0277-4.CrossRefPubMed
28.
go back to reference Seppala J, Vanhala M, Kautiainen H, Eriksson J, Kampman O, Mantyselka P, Oksa H, Ovaskainen Y, Viikki M, Koponen H: Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. J Affect Disord. 2012, 136: 543-549. 10.1016/j.jad.2011.10.032.CrossRefPubMed Seppala J, Vanhala M, Kautiainen H, Eriksson J, Kampman O, Mantyselka P, Oksa H, Ovaskainen Y, Viikki M, Koponen H: Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. J Affect Disord. 2012, 136: 543-549. 10.1016/j.jad.2011.10.032.CrossRefPubMed
29.
go back to reference Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B: Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med. 2012, 44: 279-288. 10.3109/07853890.2010.543921.CrossRefPubMed Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B: Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med. 2012, 44: 279-288. 10.3109/07853890.2010.543921.CrossRefPubMed
30.
go back to reference Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W: Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984, 226: 1342-1344. 10.1126/science.6334362.CrossRefPubMed Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W: Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984, 226: 1342-1344. 10.1126/science.6334362.CrossRefPubMed
31.
go back to reference Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H: Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 1993, 150: 810-812.CrossRefPubMed Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H: Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 1993, 150: 810-812.CrossRefPubMed
32.
go back to reference Jabben N, Nolen WA, Smit JH, Vreeburg SA, Beekman AT, Penninx BW: Co-occurring manic symptomatology influences HPA axis alterations in depression. J Psychiatr Res. 2011, 45: 1208-1213.PubMed Jabben N, Nolen WA, Smit JH, Vreeburg SA, Beekman AT, Penninx BW: Co-occurring manic symptomatology influences HPA axis alterations in depression. J Psychiatr Res. 2011, 45: 1208-1213.PubMed
33.
go back to reference Rosmond R: Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinol. 2005, 30: 1-10. 10.1016/j.psyneuen.2004.05.007.CrossRef Rosmond R: Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinol. 2005, 30: 1-10. 10.1016/j.psyneuen.2004.05.007.CrossRef
34.
go back to reference Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009, 94: 2692-2701. 10.1210/jc.2009-0370.CrossRefPubMed Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009, 94: 2692-2701. 10.1210/jc.2009-0370.CrossRefPubMed
35.
go back to reference Tentolouris N, Argyrakopoulou G, Katsilambros N: Perturbed autonomic nervous system function in metabolic syndrome. Neuromolecular Med. 2008, 10: 169-178. 10.1007/s12017-008-8022-5.CrossRefPubMed Tentolouris N, Argyrakopoulou G, Katsilambros N: Perturbed autonomic nervous system function in metabolic syndrome. Neuromolecular Med. 2008, 10: 169-178. 10.1007/s12017-008-8022-5.CrossRefPubMed
36.
go back to reference Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW: Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010, 95: 2458-2466. 10.1210/jc.2009-2801.CrossRefPubMed Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW: Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010, 95: 2458-2466. 10.1210/jc.2009-2801.CrossRefPubMed
37.
go back to reference Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H: Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008, 39: 1607-1609. 10.1161/STROKEAHA.107.508630.CrossRefPubMed Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H: Metabolic syndrome is associated with silent ischemic brain lesions. Stroke. 2008, 39: 1607-1609. 10.1161/STROKEAHA.107.508630.CrossRefPubMed
38.
go back to reference Herrmann LL, Le Masurier M, Ebmeier KP: White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008, 79: 619-624.CrossRefPubMed Herrmann LL, Le Masurier M, Ebmeier KP: White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008, 79: 619-624.CrossRefPubMed
39.
go back to reference Santos M, Gold G, Kovari E, Herrmann FR, Bozikas VP, Bouras C, Giannakopoulos P: Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke. 2009, 40: 3557-3562. 10.1161/STROKEAHA.109.548545.CrossRefPubMed Santos M, Gold G, Kovari E, Herrmann FR, Bozikas VP, Bouras C, Giannakopoulos P: Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke. 2009, 40: 3557-3562. 10.1161/STROKEAHA.109.548545.CrossRefPubMed
Metadata
Title
Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study
Authors
Atsuko Sekita
Hisatomi Arima
Toshiharu Ninomiya
Tomoyuki Ohara
Yasufumi Doi
Yoichiro Hirakawa
Masayo Fukuhara
Jun Hata
Koji Yonemoto
Yukiko Ga
Takanari Kitazono
Shigenobu Kanba
Yutaka Kiyohara
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-862

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue